Legal

Philip Qu of TransAsia Lawyers analyze regulatory and statutory progress in China’s ever flourishing TMT sector in 2024, and look at the outlook for 2025

Trump signs memorandum to restrict investments that do not serve American interests; A Jiangsu court ruled that investments in overseas crypto projects are not protected under Chinese law; and Chinese companies raise funds in hope of easing of regulations against private enterprises

2024 marked another significant year in China’s intellectual property law space. Danlei Wu of Fangda Partners examines the key developments and the indicators for further developments in the year ahead

Regulatory ratings of insurance companies include corporate governance, solvency, liability quality and asset quality / CLP Reference: 3910/25.01.07 ; Issued: 2025-01-07 ; Effective: 2025-03-01

Data centers are required to safeguard the security of the customer’s own training datasets

CSRC clarifies on the shareholding changes in takeovers of listed companies. CLP Reference: 3700/25.01.10

Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences and Healthcare Practice at Haiwen & Partners examines the implications

Casper Sek of Jingtian & Gongcheng examines the evolution and refinement of China’s data protection oversight throughout 2024

Simon Leung, Partner of Baker McKenzie, and Terry Xu, Senior Counsel at FenXun Partners, examine key regulatory shifts in 2024 and provide an outlook of potential regulatory trends for the banking and finance sector in 2025